Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00874445 · ClinicalTrials.gov registry record
Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 77
- Enrollment target
NCT00874445: Completed study, sponsored by Abbott Medical Devices.
NCT00874445 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00874445 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform in a single coil active can configuration.
Interventions
- DEVICE ICD/ CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-09 |
What the finished NCT00874445 record still lists
NCT00874445 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ICD/ CRT-D is the first listed.
NCT00874445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00874445 about?
NCT00874445 is a clinical study titled "Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration". The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform in a single coil active can configuration.
What is the current status of trial NCT00874445?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2009-03. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00874445?
The interventions under investigation include: ICD/ CRT-D (DEVICE).
Who is sponsoring clinical trial NCT00874445?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia